Met Life Investment Management, LLC Dice Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$25.86 - $46.71 $531,241 - $959,563	20,543 New	20,543 $954,000
Q2 2023 Aug 10, 2023	BUY	$25.86 - $46.71 $43,755 - $79,033	1,692 Added 8.98%	20,543 $954,000
Q1 2023 May 09, 2024	BUY	$26.05 - $32.31 $491,068 - $609,075	18,851 New	18,851 $540 Million
Q4 2022 May 10, 2024	BUY	$19.77 - $42.23 $57,926 - $123,733	2,930 Added 18.4%	18,851 $588,000
Q4 2022 Mar 22, 2023	BUY	$19.77 - $42.23 $57,926 - $123,733	2,930 Added 18.4%	18,851 $588,000
Q4 2022 Feb 15, 2023	BUY	$19.77 - $42.23 $57,926 - $123,733	2,930 Added 18.4%	18,851 $588,000
Q3 2022 Jun 14, 2023	SELL	$14.97 - $22.65 $43,862 - $66,364	-2,930 Reduced 15.54%	15,921 $322,000
Q2 2022 May 10, 2024	BUY	$13.19 - $22.1 $85,075 - $142,545	6,450 Added 68.1%	15,921 $247,000
Q2 2022 Jun 20, 2023	SELL	$13.19 - $22.1 $38,646 - $64,753	-2,930 Reduced 15.54%	15,921 $247,000
Q2 2022 Mar 22, 2023	BUY	$13.19 - $22.1 $85,075 - $142,545	6,450 Added 68.1%	15,921 $247,000
Q2 2022 Aug 11, 2022	BUY	$13.19 - $22.1 $85,075 - $142,545	6,450 Added 68.1%	15,921 $247,000
Q1 2022 May 10, 2024	BUY	$14.54 - $25.02 $137,708 - $236,964	9,471 New	9,471 $181,000
Q1 2022 Jun 20, 2023	SELL	$14.54 - $25.02 $136,385 - $234,687	-9,380 Reduced 49.76%	9,471 $181,000
Q1 2022 Mar 22, 2023	BUY	$14.54 - $25.02 $49,101 - $84,492	3,377 Added 55.42%	9,471 $181,000
Q1 2022 May 12, 2022	BUY	$14.54 - $25.02 $49,101 - $84,492	3,377 Added 55.42%	9,471 $181,000
Q4 2021 May 17, 2024	BUY	$22.41 - $37.54 $136,566 - $228,768	6,094 New	6,094 $154,000
Q4 2021 Jun 21, 2023	SELL	$22.41 - $37.54 $285,884 - $478,897	-12,757 Reduced 67.67%	6,094 $154,000
Q4 2021 Mar 22, 2023	SELL	$22.41 - $37.54 $285,884 - $478,897	-12,757 Reduced 67.67%	6,094 $154,000
Q4 2021 Feb 15, 2022	BUY	$22.41 - $37.54 $136,566 - $228,768	6,094 New	6,094 $154,000

Others Institutions Holding DICE

# of Institutions

Shares Held

17.7K

Call Options Held

13K

Put Options Held

View Full List

About DICE Therapeutics, Inc.

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

More about DICE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account